Πλοήγηση ανά Συγγραφέα "Kardasi, M."
-
Anti-cardiolipin antibodies (anti-CL) in patients with hepatitis C virus (HCV) infection are independent of beta2-glycoprotein I (b2GPI) co-factor or features of antiphospholipid syndrome (APS)
Zachou, K.; Liaskos, C.; Christodoulou, D.; Kardasi, M.; Papadamou, G.; Gatselis, N.; Gerovasilis, F.; Tsianos, E.; Dalekos, G. (2002) -
Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome
Zachou, K.; Liaskos, C.; Christodoulou, D. K.; Kardasi, M.; Papadamou, G.; Gatselis, N.; Georgiadou, S. P.; Tsianos, E. V.; Dalekos, G. N. (2003)Background Although controversial, some authorities have implicated hepatitis C virus (HCV) as a cause of anti-phospholipid syndrome (APLS). Anti-cardiolipin antibodies (anti-CLAbs) in APLS are cofactor-dependent ('pathogenic' ... -
Progressive Supranuclear Palsy (Steele-Richardson-Olszewski Syndrome) With Fatal Outcome, After the Manifestation of an Ampullary Adenocarcinoma
Manolakis, A. C.; Kardasi, M.; Tsiopoulos, F. D.; Kapsoritakis, A. N.; Psychos, A. K.; Potamianos, S. P. (2010) -
Risk factors associated with HCV infection in semi-rural areas of central Greece
Gatselis, N. K.; Rigopoulou, E.; Stefos, A.; Kardasi, M.; Dalekos, G. N. (2007)Background: Hepatitis C virus (HCV) appears to be endemic in most parts of the world, but there is considerable geographic variation. In order to assess the geographic distribution of HCV in Thessaly, in central Greece, ...